<html>
<head>PUBMED IDs for MAGEC1</head>
<body bgcolor='#C5F0F2'><h1>MAGEC1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16774536/'>Heterogeneous expression of melanoma antigen (hMAGE) mRNA in mesenchymal neoplasia.</a> June 16  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16929165/'>Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma.</a> August 25  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18237105/'>Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients.</a> February 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18426187/'>Cancer-testis (CT) antigen expression in medulloblastoma.</a> April 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18426139/'>Development of an inhaled endotoxin challenge protocol for characterizing evoked cell surface phenotype and genomic responses of airway cells in allergic individuals.</a> April 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21810217/'>NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene.</a> February 7  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22110734/'>Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines.</a> March 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22411186/'>Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.</a> October 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22411169/'>Airway epithelial cell differentiation during lung organogenesis requires C/EBPα and C/EBPβ.</a> September 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22411136/'>Polymorphism of HMGA1 is associated with increased risk of type 2 diabetes among Chinese individuals.</a> August 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22411123/'>Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia.</a> October 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22411106/'>Predicting Homo pigmentation phenotype through genomic data: from Neanderthal to James Watson.</a> January 11  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23156676/'>[Early detection of cancer/testis mRNAs in tumor cells circulating in the peripheral blood of colorectal cancer patients].</a> December 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24232866/'>Cancer testis antigen expression in testicular germ cell tumorigenesis.</a> January 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24627082/'>Biological characterization and analysis of metastasis-related genes in cell lines derived from the primary lesion and lymph node metastasis of a squamous cell carcinoma arising in the mandibular gingiva.</a> November 14  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24627079/'>Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology.</a> January 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24795360/'>Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions.</a> December 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24820265/'>Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.</a> January 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24842123/'>YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.</a> January 15  2014<br></body></html>
